Frese Julia, Morgenroth Agnieszka, Mertens Marianne E, Koch Sabine, Rongen Lisanne, Vogg Andreas T J, Zlatopolskiy Boris D, Neumaier Bernd, Gesche Valentine N, Lammers Twan, Schmitz-Rode Thomas, Mela Petra, Jockenhoevel Stefan, Mottaghy Felix M, Kiessling Fabian
Biomed Tech (Berl). 2014 Apr 1;59(2):165-75. doi: 10.1515/bmt-2013-0029.
Abstract Tissue engineering as a multidisciplinary field enables the development of living substitutes to replace, maintain, or restore diseased tissue and organs. Since the term was introduced in medicine in 1987, tissue engineering strategies have experienced significant progress. However, up to now, only a few substitutes were able to overcome the gap from bench to bedside and have been successfully approved for clinical use. Substantial donor variability makes it difficult to predict the quality of tissue-engineered constructs. It is essential to collect sufficient data to ensure that poor or immature constructs are not implanted into patients. The fulfillment of certain quality requirements, such as mechanical and structural properties, is crucial for a successful implantation. There is a clear need for new nondestructive and real-time online monitoring and evaluation methods for tissue-engineered constructs, which are applicable on the biomaterial, tissue, cellular, and subcellular levels. This paper reviews current established nondestructive techniques for implant monitoring including biochemical methods and noninvasive imaging.
摘要 组织工程作为一个多学科领域,能够开发出活体替代物来替换、维持或修复患病组织和器官。自1987年该术语被引入医学领域以来,组织工程策略取得了显著进展。然而,截至目前,只有少数替代物能够跨越从实验室到临床应用的差距,并已成功获批用于临床。供体的巨大变异性使得难以预测组织工程构建体的质量。收集足够的数据以确保不良或未成熟的构建体不被植入患者体内至关重要。满足某些质量要求,如机械和结构特性,对于成功植入至关重要。显然需要新的无损且实时在线监测和评估组织工程构建体的方法,这些方法适用于生物材料、组织、细胞和亚细胞水平。本文综述了当前用于植入物监测的既定无损技术,包括生化方法和非侵入性成像。